Many years ago, Professor Gao Yihuai, an internationally renowned scientist in New Zealand, founded Anfa International Holding Group, an international health industry group integrating research, production, marketing and science popularization.
Since its inception, Anfa International Holdings has been committed to the research of natural resources such as edible and medicinal fungi, natural plants, marine organisms and nutritious fruits and vegetables. Then, Anfa was based in China to build a new natural medicine kingdom for the world.
Science and technology is the foundation of Anfa's business, and hard work is the soul of Anfa's entrepreneurship. After more than 30 years of exploration, the scientific research team led by Professor Gao Yihuai has gradually proposed and improved the theory of the relationship between the three universities in the history of medicine, and also unveiled the relationship between molecular structure, combination, dosage and efficacy at the level of biochemistry and molecular biology through practice, which has built a bridge for the integration and complementarity of traditional medicine and Western medicine, and realized a modern revolution in traditional medicine that has attracted the attention of the world.
In 2013, Professor Gao was recommended as a Foreign Member of the Russian Academy of Engineering for his outstanding achievements in the field of active polysaccharides and biotechnology.
On August 13, 2023, at the Sino-Russian Academician Seminar on Engineering Innovation Cooperation, three vice-presidents of the Russian Academy of Engineering, professors and chief researchers of the Institute of Mechanics of the Russian Academy of Sciences jointly awarded Professor Gao Yihuai the certificate and badge of foreign academician of the Russian Academy of Engineering.
On October 19, 2023, Professor Gao led R&D Biology to sign a strategic cooperation framework agreement with the Russian Academy of Engineering, working with the Russian Academy of Engineering to develop Chinese and Russian medicinal resources, promote the integration of the natural medicine industry into the Belt and Road Initiative, and jointly promote the development of human health.
After 25 years of trials and hardships, Anfa Biotech has made extraordinary achievements. With its leading technology and high-quality health care products, the group has won praise and unanimous recognition from customers around the world.
Dual-core drive, with medical faucet
On December 15, 2023, Anfa Biotech (Fujian) Technology Co., Ltd. kicked off its 25th anniversary annual meeting in Chongqing.
Professor Gao Yihuai delivered a speech at the conference and pointed out the grand enterprise upgrading strategy of Anfa Biotech driven by dual core and led by medical with a commanding position.
Anfa's new development strategy is based on the development direction of the national health industry, and actively promotes the implementation plan of major projects for the revitalization and development of traditional Chinese medicine, which also conforms to the background of the great era.
In 2021, the board of directors of Anfa Group put forward the third entrepreneurial slogan of famous schools, strong foundations, integrity and innovation, and dual-core drive, the so-called dual-core is to focus on the two operating cores of direct selling and traditional (medicine), and focus on creating a development model in which the three carriages go hand in hand.
2023 is the twenty-fifth year of the establishment of Anfa International Group, and the company has gone very steadily and far. In the past 25 years, Anfa Biotech has not only laid a solid hardware foundation and a scientific and technological and cultural foundation for future generations, but also laid an excellent industrial reputation, and is far ahead in the health care products industry and the pharmaceutical and biological industry. Anfa Group has overcome all the obstacles and has paid as much as 1.5 billion yuan in taxes for the country so far, and is also determined to become a century-old scientific research enterprise.
2022 is a turning year, Anfa Biotech has attracted a strong metamorphosis and upgrading, put forward the overall layout of the Materia Medica medical project, and in the following 2023, Anfa Group will formulate the Materia Medica project model and plan to vigorously promote the Materia Medica medical project in 2024.
As a result, Anfa Biotech has gradually embarked on a unique path of integration of medical care and elderly care.
According to the data at the annual meeting, at the beginning of the Materia Medica project, from April 2022 to April 2023, Anfa has established a total of 250 modern Chinese medicine outpatient clinics across the country, launched modern Chinese medicine formulas and products corresponding to 100 major diseases, established six modern pharmacies, and prescribed more than 99,000 Danfangs.
For Anfa, data is just the beginning of the Materia Medica project. Anfa Biotech plans to increase the number of stores in the Materia Medica project to 600-800 in 2023, and expects to increase the total number of stores to 1,000 in three years at the earliest, when the project can benefit about 10 million people to live a healthy life.
In order to encourage the start of the Anfa Materia Medica Project, Ningde City** has specially provided 38 acres of land for it to support further investment in scientific research and technology.
Anfa's dual-core drive has been on the right track in the past few years, and the transformation of medicine as the leader is also in full swing.
The so-called strategy of taking medicine as the leader is to no longer take health care products as the leader in a single line, but shift the focus of construction to the medical sector, take medical care as the leader, and lead Anfa to go further and fly higher.
The combination of Chinese and Western, Anfa flywheel
Whether it is Professor Gao Yihuai's speech at the annual meeting of Anfa or the scientific research attitude of the guests, they are trying their best to show us the vigorous and heroic posture of a health industry leader based on scientific research and academics.
When it comes to the field that Anfa is best at, it must be polysaccharides, which is also a rigorous idea of combining Chinese and Western medicine, and a high-level investment in scientific innovation - Anfa has been committed to the in-depth research and integration of Chinese and Western medicine since its birth.
Since its establishment in 2005, Anfa International has adhered to scientific and technological innovation as the source of enterprise development, and has gradually built itself into a large-scale demonstration project including national high-tech enterprises, national intellectual property advantage enterprises, and national forestry key leading enterprises.
How to inherit and carry forward the treasure of traditional Chinese medicine in an orderly manner has always been the ultimate goal of all national scientists and entrepreneurs, and Professor Gao Yihuai is not only an outstanding scientist, but also a great entrepreneur.
Under the leadership of Professor Gao Yihuai, Anfa Biotech pays attention to the introduction of advanced scientific methods and corresponding knowledge from the West, and combines Chinese and Western medicine in the medical field.
At the same time, Anfa continues to carry out the integration of medical care and elderly care, and carries out research on the prevention of diseases, and the development of this field has also witnessed the results of the combination of medicine and health, that is, the perfect transformation of scientific academia to commercial.
In the future, Anfa Biotech will likely introduce more scientific research strength, consolidate the integration and innovation of Chinese and Western medicine, and achieve more complete achievements on the unique road of medicine and health.